**Page:** 122

|                                        | Year Ended December 31,   | Year Ended December 31,   | Year Ended December 31,   |
|----------------------------------------|---------------------------|---------------------------|---------------------------|
|                                        | 2023                      | 2022                      | 2021                      |
| Cost of revenue                        | $ 740                     | $ 768                     | $ 577                     |
| Research and development               | 11,429                    | 9,361                     | 7,106                     |
| Marketing and sales                    | 952                       | 1,004                     | 837                       |
| General and administrative             | 906                       | 859                       | 644                       |
| Total share-based compensation expense | $ 14,027                  | $ 11,992                  | $ 9,164                   |
The following table summarizes the activities for our unvested RSUs for the year ended December 31, 2023:

|                               | Number of Shares (in thousands)   | Weighted-Average Grant Date Fair Value Per Share   |
|-------------------------------|-----------------------------------|----------------------------------------------------|
| Unvested at December 31, 2022 | 127,110                           | $ 216.93                                           |
| Granted                       | 112,066                           | $ 202.46                                           |
| Vested                        | (65,402)                          | $ 210.74                                           |
| Forfeited                     | (24,712)                          | $ 210.39                                           |
| Unvested at December 31, 2023 | 149,062                           | $ 209.85                                           |